Prudential Financial’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.15M Buy
190,910
+42,005
+28% +$1.55M 0.01% 837
2025
Q4
$6.27M Sell
148,905
-13,398
-8% -$540K 0.01% 818
2025
Q3
$5.57M Buy
162,303
+125,185
+337% +$3.59M 0.01% 865
2025
Q2
$1M Buy
37,118
+23,785
+178% +$689K ﹤0.01% 1663
2025
Q1
$475K Sell
13,333
-108,670
-89% -$4.14M ﹤0.01% 1860
2024
Q4
$4.83M Buy
122,003
+104,639
+603% +$3.96M 0.01% 889
2024
Q3
$591K Sell
17,364
-20,564
-54% -$579K ﹤0.01% 2142
2024
Q2
$822K Sell
37,928
-23,919
-39% -$503K ﹤0.01% 1948
2024
Q1
$1.37M Sell
61,847
-61,312
-50% -$1.5M ﹤0.01% 1667
2023
Q4
$3.39M Sell
123,159
-57,035
-32% -$1.38M 0.01% 1136
2023
Q3
$4.02M Sell
180,194
-127,302
-41% -$3.27M 0.01% 993
2023
Q2
$7.83M Sell
307,496
-65,262
-18% -$1.58M 0.01% 735
2023
Q1
$8.31M Sell
372,758
-21,005
-5% -$508K 0.01% 703
2022
Q4
$9.34M Buy
393,763
+117,630
+43% +$2.73M 0.02% 652
2022
Q3
$4.58M Buy
276,133
+68,738
+33% +$1.55M 0.01% 911
2022
Q2
$4.13M Buy
+207,395
New +$4.19M 0.01% 983
2022
Q1
Sell
-81,105
Closed -$4.26M 2699
2021
Q4
$4.26M Buy
81,105
+27,693
+52% +$1.22M 0.01% 1111
2021
Q3
$2.48M Buy
53,412
+6,967
+15% +$304K ﹤0.01% 1343
2021
Q2
$1.86M Sell
46,445
-217,503
-82% -$9.3M ﹤0.01% 1518
2021
Q1
$14.2M Buy
263,948
+258,845
+5,072% +$14.9M 0.02% 631
2020
Q4
$249K Sell
5,103
-3,540
-41% -$164K ﹤0.01% 2299
2020
Q3
$281K Buy
+8,643
New +$275K ﹤0.01% 2185
2020
Q1
Sell
-191,663
Closed -$5.35M 2445
2019
Q4
$5.35M Sell
191,663
-479,043
-71% -$12.4M 0.01% 1093
2019
Q3
$16.1M Sell
670,706
-103,893
-13% -$2.76M 0.03% 626
2019
Q2
$22.1M Buy
774,599
+365,015
+89% +$9.12M 0.03% 539
2019
Q1
$10.2M Buy
409,584
+300,295
+275% +$5.73M 0.02% 830
2018
Q4
$1.38M Buy
109,289
+49,719
+83% +$588K ﹤0.01% 1705
2018
Q3
$569K Buy
+59,570
New +$657K ﹤0.01% 2020

Other funds holding VCYT

Prudential Financial's VCYT Position: Q1 2026 in Review

Prudential Financial increased its Veracyte (VCYT) stake by 28% in Q1 2026, buying an estimated $1.55M and bringing the position to 190,910 shares worth $6.15M. The position accounts for 0.01% of the portfolio, ranked #837.

Prudential Financial first reported a position in VCYT in Q3 2018 and has held it in 28 quarters since. The position peaked at $22.1M in Q2 2019. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • Prudential Financial held 190,910 shares of Veracyte worth $6.15M as of Q1 2026.
  • Prudential Financial bought 42,005 Veracyte shares in Q1 2026, an estimated $1.55M.
  • Veracyte made up 0.01% of Prudential Financial's portfolio in Q1 2026, its #837 holding.
  • Prudential Financial first reported a position in Veracyte in Q3 2018 and has held it in 28 quarters since.
  • Prudential Financial's Veracyte position peaked at $22.1M in Q2 2019.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.